We describe a PFIC2 patient with a good response to ursodeoxycholic acid for 9 years. We found two novel ABCB11 gene mutations in the patient, i.e. I498T and 2098delA. The correlation of the patient's genotypes with the clinical course supports the existence of a phenotypic continuum between BRIC2 and PFIC2.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2005.09.013DOI Listing

Publication Analysis

Top Keywords

novel abcb11
8
abcb11 gene
8
gene mutations
8
bric2 pfic2
8
patient novel
4
mutations phenotypic
4
phenotypic transition
4
transition bric2
4
pfic2 describe
4
describe pfic2
4

Similar Publications

The novel prognostic analysis of AML based on ferroptosis and cuproptosis related genes.

J Trace Elem Med Biol

December 2024

Department of Hematology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China; Jiangxi Province Key Laboratory of Hematologic Diseases, Nanchang 330006, China; National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Soochow 215006, China. Electronic address:

Background: Acute myeloid leukemia (AML) is a hematological malignancy. The aim of this research was to develop a ferroptosis and cuproptosis related novel prognostic signature associated with AML.

Methods: The ferroptosis and cuproptosis related genes correlated with the prognosis of AML were identified by univariate Cox analysis.

View Article and Find Full Text PDF

Progressive familial intrahepatic cholestasis (PFIC) is a rare childhood manifested disease associated with impaired bile secretion with severe pruritus yellow stool, and sometimes hepatosplenomegaly. PFIC is caused by mutations in ATP8B1, ABCB11, ABCB4, TJP2, NR1H4, SLC51A, USP53, KIF12, ZFYVE19, and MYO5B genes depending on its type. ABCB11 mutations lead to PFIC2 that encodes the bile salt export pump (BSEP).

View Article and Find Full Text PDF

Farnesoid X Receptor: Effective alleviation of rifampicin -induced liver injury.

Int Immunopharmacol

September 2024

Key Laboratory of Receptors-Mediated Gene Regulation, School of Basic Medical Sciences, Henan University, Henan, PR China; Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Science, Inner Mongolia Medical University, Hohhot, Inner Mongolia, PR China. Electronic address:

Antituberculosis drugs induce pharmacologic cholestatic liver injury with long-term administration. Liver injury resulting from rifampicin is potentially related to the bile acid nuclear receptor Farnesoid X Receptor (FXR). To investigate this, cholestasis was induced in both wild-type (C57BL/6N) mice and FXR knockout (FXR-null) mice through administration of rifampicin (200 mg/kg) via gavage for 7 consecutive days.

View Article and Find Full Text PDF

What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches.

Curr Opin Pediatr

October 2024

Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, Canada.

Purpose Of Review: To highlight recent advances in pediatric cholestatic liver disease, including promising novel prognostic markers and new therapies.

Findings: Additional genetic variants associated with the progressive familial intrahepatic cholestasis (PFIC) phenotype and new genetic cholangiopathies, with an emerging role of ciliopathy genes, are increasingly being identified. Genotype severity predicts outcomes in bile salt export pump (BSEP) deficiency, and post-biliary diversion serum bile acid levels significantly affect native liver survival in BSEP and progressive familial intrahepatic cholestasis type 1 (FIC1 deficiency) patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!